Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KamRho-D in Postpartum Rh-negative Women
NCT01666249Phase 3Suspended
- Sponsor
- Azidus Laboratories Limited
- Start
- Apr 2014
- Primary completion
- Nov 2014
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rho(d) immune globulin in Rhesus isoimmunization, sponsored by Azidus Laboratories Limited. Started Apr 2014; status: suspended.
02
Drugs
rho(d) immune globulin
03
Conditions
Rhesus isoimmunization
Beyond the preview
Go deeper on NCT01666249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01666249.